December 2025
M&A Deals What We Offer Consulting Support Free Tools MD Insights
Whether you’re an SME founder, investment banker, or financial investor — this monthly update is built for you.
👉 Scroll down to explore opportunities and tools tailored to your role.
The buyer is seeking acquisition or majority stake opportunities in businesses that have strong brand equity or well-established B2B relationships, supported by a capable management team and scalable operations. Ideal targets should exhibit healthy margins and strong growth potential across both domestic and export markets, with clear opportunities for operational improvements and value creation through strategic and financial restructuring. The sectoral focus includes industrial manufacturing, specifically companies involved in components, chemicals, or materials with meaningful export linkages.
Read moreThe buyer is seeking acquisition or majority stake opportunities in businesses that demonstrate strong brand equity or well-established B2B relationships, backed by a sound management team and scalable operations. Ideal targets should have healthy margins and exhibit solid growth potential in both domestic and export markets, along with clear scope for operational enhancement and value creation through strategic and financial restructuring. The sectoral focus is on the pharmaceuticals space, specifically companies involved in generic formulations, APIs, and contract manufacturing units.
Read moreThe buyer is seeking a currently running and profitable business that holds all necessary regulatory approvals and licenses. The preferred location is Maharashtra, though operations that can be relocated are also acceptable. The target should be engaged in the manufacture of OTC medicines and/or be prepared for API manufacturing, supported by suitable manufacturing infrastructure and strong quality assurance systems. A well-established distribution or marketing network is essential. Ideally, the business should be available for sale due to succession challenges or an inability to scale further. The buyer is prepared to invest up to ₹10 crores for the right opportunity.
Read moreA unique opportunity to acquire two fully operational, independent 3-star hotels located near an airport in eastern India. Both freehold and debt-free, the properties were recently renovated (2023–25) and provide a turnkey entry into the high-demand mid-scale hospitality segment. Operating under independent brands, they attract corporate, airline crew, and transit travelers. The portfolio—available via asset, SPV, or full portfolio sale—offers legally compliant assets with clear approvals, minimal capex needs, stable profitability, and strong PAT performance. Combined asking price: ₹375 crore.
Read moreA leading IFM and business support services provider headquartered in Western India, the company has been operating since 2002 and serves 200+ clients across 14 states with a 20,000+ workforce. Backed by BII and previously India Nivesh, it has demonstrated strong governance, consistent profitability, and a 27% revenue CAGR since FY18, reaching ₹489 Cr in FY25A and projected ₹940 Cr in FY26E. Its tech-enabled operations leverage IoT, ERP, and automation to deliver IFM, specialized cleaning, and technical support services across sectors such as BFSI, airports, healthcare, and retail. With high client retention and a diversified portfolio, the company is well-positioned for its next phase of growth.
Read moreThe company is a well-established pharmaceutical manufacturer producing dry powder injections, dry syrups, and sterile water for injection, and is currently upgrading its facilities to add Large Volume Parenterals (LVPs). It operates under a CDMO model with long-standing clients such as Aristo, Akums, Glenmark, and Mankind, ensuring stable margins through a cost-plus structure and P2P arrangements for sterile water. The business runs two WHO-GMP and Schedule M compliant units—one dedicated to beta-lactam products and another for sterile water and upcoming LVPs—supported by strong installed capacities and ongoing regulatory audits for African market entry. Existing products include dry powder formulations and sterile water, with LVPs soon to be added post-upgradation.
Read moreThe buyer is seeking acquisition or majority stake opportunities in businesses with strong brand equity or well-established B2B relationships, supported by a capable management team and scalable operations. Ideal companies should demonstrate healthy margins and strong growth potential across domestic and export markets, along with clear scope for operational improvement and value creation through strategic and financial restructuring. The sectoral focus is on the apparel and lifestyle space, including branded garments, textile manufacturing units, and export-oriented operations.
Read moreThe buyer aims to invest in scalable, asset-backed, and compliant businesses within the specialty and cosmetic chemicals manufacturing segment, while remaining open to other high-potential B2B manufacturing sectors and diversified industrial categories such as electrical hardware, lubricants, polymers, and precision engineering components. Preferred targets should be located across India—especially in the South, West, or East—and operate on a B2B model in manufacturing, exports, or contract production. The investor seeks a majority or controlling stake in businesses with compliant, scalable plants and strong operational foundations. The fund intends to unlock value through enhanced capacity utilization, operational optimization, and expanded market reach.
Read moreThe buyer is seeking scalable, asset-backed, and compliant businesses in the API manufacturing segment, while also remaining open to high-potential B2B manufacturing sectors and diversified industrial opportunities such as electrical hardware, lubricants, polymers, and precision engineering components. Preferred targets operate on a B2B manufacturing, export, or contract production model and are located across India, with a focus on South, West, and East industrial clusters. The investor seeks a majority or controlling stake in companies with compliant, scalable plants and strong operational foundations, aiming to unlock value through capacity enhancement, operational efficiency, and expanded market reach.
Read moreThe company is a well-established FMCG tea brand operating from a fully automated 50,000 sq. ft. facility in Northern India, with a production capacity of 500 tons per month and packaging capability of 14 crore packs per month (currently at ~43% utilization). With 30+ SKUs across premium and value segments, it has a strong presence in retail and CSD channels, generating ₹25 Cr from CSD alone and aiming to scale this to ₹60–70 Cr. The facility includes advanced blending and flavoring systems along with 14 packaging machines, supporting a diverse product range that includes green tea, lemon tea, white tea, and more.
Read moreThis opportunity offers a 26,000 sq. ft. freehold land parcel in a rapidly growing district of Kerala, ideal for developing a 5-star hotel with 60–75 rooms and full amenities. The dual-zoned land—mostly barren and dispute-free—has already attracted interest from multiple international hotel operators willing to manage the property once built. With a development budget of ₹35–55 Cr, the project benefits from zero competition in the 4/5-star segment, strong district tourism of 22 lakh visitors annually, and attractive financials including a 7–9 year payback, 33–57% ROI within 5 years, and low breakeven occupancy of 37%, supported by high-earning segments such as restaurants, bars, and event/conference facilities.
Read moreThis institutional-grade beverage manufacturing asset, located in Daman’s prime industrial corridor, offers a turnkey operational platform with scalable infrastructure and strong industrial zoning benefits. Spread across 12,000 sq. m of industrial land with a 69,000 sq. ft. RCC facility and residual FSI for expansion, it includes a fully integrated beverage production line requiring minimal additional capex. The facility’s versatile layout supports beverage, food, pharma, plastics, and textile manufacturing, making it suitable for investors seeking high-quality industrial or manufacturing real estate. The asset is available for outright purchase or long-term lease with flexible structuring options, including sale-leaseback.
Read moreThe company is a fast-growing Oncology API manufacturer recently acquired by a diversified pharmaceutical group with interests spanning formulations, distribution, retail, and exports. It operates a world-class API facility in Maharashtra compliant with ISO, GMP, and ICH standards, serving both regulated and semi-regulated markets. The business forms one of the group’s key verticals and functions as a dedicated subsidiary within the broader pharmaceutical portfolio.
Read moreProject Lightning is a fully indigenous, smart EV charging solutions provider focused on the high-growth DC fast-charging segment for 2W, 3W, and 4W electric vehicles. With a full-stack model integrating proprietary hardware, software, and services, the company maximizes asset lifetime value, supported by a strong recurring revenue stream—26% of charger LTV comes from high-margin AMC and spare parts. Its products are already deployed across 210+ locations nationwide, with plans to scale to over 1,000 sites, targeting a DC charging market projected to require 1.75 lakh+ fast chargers by 2030. The current round involves dilution, with valuation underway.
Read moreProject Datalift is a global IT and AI services provider specializing in Databricks, Generative AI, and data-driven transformation solutions. The company helps enterprises build scalable, insight-driven ecosystems to accelerate growth through AI automation, advanced analytics, and data engineering. Its offerings include Databricks implementation, AI and machine learning solutions, advanced analytics, cloud and data modernization, and digital transformation consulting, alongside proprietary AI modules such as Datalift AI Studio, KnowledgeGPT, and AI Commerce Optimizer. Supported by a team of 150+ professionals, including IIT/IIM alumni and former leaders from Accenture, PwC, Cognizant, and Amazon, the company serves a global client base, including Fortune 500 firms.
Read moreProject Vertex is an AI-native Skills & Knowledge Intelligence platform that enhances customer-facing teams through hybrid Humans + AI Agents, leveraging Agentic AI to boost productivity, onboarding, and customer interactions. Adopted by 30+ global enterprises with 150K+ paid users across 32 customers in 15 months, it generates $625K ARR—70% from international markets—with 81% monthly active usage and 90% customer satisfaction. Targeting a $493B global market, including $50B in frontline sales and operations, the platform offers unique IP such as Emotional Intelligence Assistants, Agentic Content Assistants, autonomous AI agents, and AI simulations, displacing incumbents like SAP and Absorb. Its integrated solution combines course building, workforce capability assessment, and real-time assistance, supported by a 20+ member team.
Read moreThe company is an AI-enabled Transfer Pricing Benchmarking SaaS platform that automates a critical tax compliance function across 130+ countries, offering fast, accurate, and cost-effective analysis for multinational corporations and consulting/law firms. Leveraging AI and expert validation, it delivers robust benchmarking studies that withstand audits and litigation, preparing reports in 14–16 hours while enabling 60–70% cost savings. The platform ensures 100% compliance and serves a global market estimated at US$41 billion, offering AI-powered benchmarking studies, automated qualitative analysis, margin computation, report generation, annual compliance support, and scalable API integration for enterprise systems.
Read moreA $30 billion turnover manufacturing conglomerate with operations in over 50 countries is actively seeking acquisitions in the aerospace and defense sectors. The ideal target should be EBITDA-positive with a minimum revenue of ₹100 crore. The conglomerate does not require fee-sharing arrangements for the transaction.
Read moreA leading U.S.-based Fortune 500 company is looking to expand its IT services presence in the healthcare and pharmaceutical technology sector in India. The acquisition targets companies with strong domain expertise and a credible client base in healthcare or pharma IT, including revenue cycle management, digital health platforms, life sciences data solutions, EMR/EHR integration, compliance, and analytics, aiming to strengthen the buyer’s healthcare-focused capabilities and India-based service delivery.
Read moreWin investor trust with a strong financial model, credible valuation, and a compelling business narrative that showcases your growth potential.
Leverage our free Valuation Tool and Deal Summary Generator to create essential documents that make your business stand out.
Post your requirement anonymously — only verified buyers see your deal.
We assist in building a detailed Financial Model and Information Memorandum (IM) to strengthen your business case.
Our analysts reach out to 500+ buyers, 800+ investment bankers, and relevant stakeholders beyond the platform.
Receive expressions of interest and get handholding support through meetings, negotiations, and closure.
From deal posting to final negotiation, our team works closely with you at every step.
Win investor confidence with a robust financial model, a defensible valuation and a narrative that highlights your growth potential.
Use our free Valuation Tool and Deal Summary Generator to quickly prepare key documents.
Post your fundraise requirement anonymously - only verified investors can view your deal.
We assist in building a detailed Financial Model and Information Memorandum (IM) to strengthen your investor pitch.
Our analysts reach out to 500+ investors, 800+ investment bankers, and relevant stakeholders beyond the platform.
Receive expressions of interest and get handholding support through meetings, negotiations, and closure.
From deal posting to final transaction, our team works closely with you at every step.
Whether you are an investor or a strategic buyer, MergerDomo makes your deal making faster and efficient.
As an investor, create your investor card to present your mandate to fund seekers and advisors.
Post your buyside requirement anonymously to receive vetted acquisition opportunities.
Make quicker decisions using real time industry multiples via free valuation tool.
Our analysts reach out to 1500+ Corporates, 800+ investment bankers, and relevant stakeholders beyond the platform.
Receive quality EOI and guidance in arranging meetings and in providing advisory support.
Receive end-to-end support from deal posting/investor card creation to final deal closure.
Raising funds or selling your business requires preparation — investors look for structured, data-backed documentation and clarity during the due diligence process. Our CaaS offering ensures you're ready to meet those expectations with confidence.
Key documents required:
With these materials in place, you shorten deal timelines, improve credibility and focus your energy on strategic conversations rather than document creation.
Know more
A weekly email guide designed for strategic buyers and investors in finding the right deals faster while avoiding common pitfalls.
Find the right deals with speed, clarity and proven methods.
Master due diligence, negotiations, and post-deal actions.
Use sensible, experience-based guidance to steer clear of typical pitfalls.
With over 2,300+ users, 120+ active M&A and fundraise deals, 500+ investors, and 800+ investment bankers, MergerDomo helps you execute faster, better, smarter.
Key Service offerings:
Whether you're looking to raise funds, explore M&A opportunities, or discover curated deals — our team is here to assist you at every step.